Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
In United States, the rising cases of Knee Arthritis, Hip Osteoarthritis has led the emerging demand for viscosupplementation market. Viscosupplementation is ideally a gel like fluid known as hyaluronic acid. It is natural substance present in the joint fluid that acts as lubricant to enable the movement of bone in knee and other arthritis condition smoothly. The market provides major benefits for reducing the pain, swelling in Knee Arthritis, Hip Osteoarthritis which has led the growing demand across the United States. Furthermore, increasing spending in healthcare is the key factor accelerating the growth of market.
The major driving factor for the market growth in United States is rising old age population suffering from Knee Arthritis, Hip Osteoarthritis due to age factor, bone density, and rising prevalence of arthritis in old age group has increased the demand for viscosupplementation market. Additionally, increasing incidence of knee osteoarthritis has fuelled the growth of market to huge extent. Likewise, integration of proprietary technology has offered significant opportunities for the market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the United States viscosupplementation market. In addition, complete analysis of changes on the United States viscosupplementation market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The viscosupplementation market comprises of different market segment like product, hyaluronic acid type, application, and end-user
By product, the viscosupplementation market includes key segment of single injection, three injection, and five injection. Three injection lead in the United States market owing to growing requirement for reducing the pain and swelling in the knee arthritis, hip osteoarthritis and others. Furthermore, the three injection adds an advantage for low rate of complications which is expected to fuel the growth market during the estimated time period. Also, single injection is likely to witness growth at highest pace during due to rapid adoption of segment in the country.
The viscosupplementation market, includes different hyaluronic acid type like stabilized hyaluronic acid, standard hyaluronic acid. Stabilized hyaluronic acid is expected to register major market share owing key benefits provided like reducing pain and swelling which has led the demand for market in the country. Also, standard hyaluronic acid is estimated to grow at moderate pace during the estimated time period. The new innovation, research for standard hyaluronic acid is the key factor boosting the growth of segment.
The viscosupplementation market finds its major application in knee arthritis, hip osteoarthritis and others. Knee arthritis is anticipated to lead in the United States viscosupplementation market by application. The factor contributing in the segment growth are increasing knee injuries, growing geriatric population and rising prevalence of knee arthritis has increased the demand for the market in the United States. Additionally, hip osteoarthritis is expected to witness rising demand in upcoming years due to increasing cases of hip osteoarthritis, and rising obesity cases which has led the requirement for viscosupplementation market in United States
The viscosupplementation market has different end user like hospitals, orthopedic clinics/ambulatory surgical centers (ascs). Hospitals has gained major market share in the United States attributing to growing sport injuries, fractures trauma and hip injuries. The rising patient inflow in hospitals for treatment has further boosted the demand for the market. Furthermore, healthcare spending for treatment and awareness for treatment has accelerated the growth of market. Likewise, orthopedic clinics/ambulatory surgical centers (ascs) is anticipated to hold second position in the market during the forecast period.
The key players in viscosupplementation market are Anika Therapeutics, Inc. , Aptissen SA , Bioventus, Singclean ,CROMA-PHARMA, Dr. Reddy's Laboratories, Ferring Pharmaceuticals, Fidia Pharma USA Inc , BioPolymer GmbH & Co. KG, Johnson & Johnson, LG Life Sciences, LABRHA International , Virchow biotech, Sun Phrama , Mylan, OrthogenRx , Roche, Ettsons , Sanofi Genzyme, Seikagaku Corporation, Smith & Nephew, Stellar Phamaceuticals Inc, Tecnofarma S.A., TRB Chemedica International, Wellchem Pharmaceuticals Pte Ltd., Zimmer Biomet
February 2020: Anika therapeutics Inc. acquired Arthosurface, which is a leading privately-held provider of joint surface and preservation solutions for active patients. This acquisition will significantly enhance the commercial capabilities in the U.S. and expand the product platform strategy.
December 2019: Fidia pharma USA Inc. introduced TRILURON in the U.S. It is a 3 injection product for the treatment of osteoarthritis. It also completes the HA viscosupplement portfolio offering for Fidia Pharma USA Inc.
June 2019: Sun Pharma had announced late-breaking phase 2 Data Showing Potential of ILUMYA (tildrakizumab-asmn) to improve joint and skin symptoms of psoriatic arthritis. It is approved in the U.S. for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and is being investigated for psoriatic arthritis.
January 2019: Bioventus launched Durolane, single injection joint fluid osteoarthritis treatment in Malaysia and selected Athrotech as its exclusive distribution partner for market. Arthotech is beneficial for Bioventus as it continues to grow in Asia and expand the reach and Malaysia is the fourth market in Asia where Durolane is introduced.
The report analyses the United States viscosupplementation market based on by product, hyaluronic acid type, application, and end-user. By product, the viscosupplementation market includes key segment of single injection, three injection, and five injection. Three injection lead in the United States market owing to growing requirement for reducing the pain and swelling in the knee arthritis, hip osteoarthritis and others. The viscosupplementation market, includes different hyaluronic acid type like stabilized hyaluronic acid, standard hyaluronic acid. Stabilized hyaluronic acid is expected to register major market share owing key benefits provided like reducing pain and swelling which has led the demand for market in the country. The viscosupplementation market finds its major application in knee arthritis, hip osteoarthritis and others. Knee arthritis is anticipated to lead in the United States viscosupplementation market by application. The viscosupplementation market has different end user like hospitals, orthopedic clinics/ambulatory surgical centers (ascs). Hospitals has gained major market share in the United States attributing to growing sport injuries, fractures trauma and hip injuries.
Why to buy this report:
